Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Activity Code(s) Sort ascending Title
PAR-22-101 October 18, 2024 R21 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
PAR-22-109 May 8, 2025 R21 Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
NOT-OD-22-142 March 17, 2025 R21 Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional)
PAR-24-161 May 8, 2027 R21 New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
RFA-MH-25-171 October 10, 2026 R21 BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
PAR-21-355 November 17, 2024 R21 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
PAR-23-131 May 8, 2026 R21 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
NOT-OD-24-026 July 16, 2024 R21 Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)
RFA-OD-23-013 June 21, 2024 R21 Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional)
PA-20-196 January 8, 2025 R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
PAR-23-294 November 19, 2026 R21 Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
PAR-24-046 November 20, 2024 R21 Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
PAR-24-045 November 20, 2024 R21 Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
PAR-23-159 October 18, 2024 R21 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
PAR-23-299 January 8, 2027 R21 Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)
PA-20-195 January 8, 2025 R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
RFA-MH-25-186 August 14, 2024 R21 Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)
PA-20-194 January 8, 2025 R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
RFA-EY-23-001 June 16, 2026 R21 BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
PAR-23-296 September 8, 2026 R21 Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
top of pageBACK TO TOP